证券记录 · 已归档季度
EXAS
Exact Sciences Corporation · Healthcare · Medical - Diagnostics & Research
17被追踪持有人
-2Δ持有人
51.51M持有股份
$2.23B报告持仓市值
+1新建仓位
−3清仓
动量输入（同类管理人）：
持有人广度 -10.5% ·
股份流向 -0.6% ·
净新建仓位 -11.8%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 1 | -143 | 11.48K | $1.20M | n/a | −144 |
| Q4 2025 | 146 | +2 | 107.45M | $10.91B | +5 | −2 |
| Q3 2025 | 23 | +1 | 95.08M | $5.20B | +1 | −1 |
| Q2 2025 | 20 | 0 | 105.61M | $5.61B | n/a | n/a |
| Q1 2025 | 17 | -2 | 51.51M | $2.23B | +1 | −3 |
| Q4 2024 | 19 | +2 | 51.81M | $2.91B | +3 | −1 |
| Q3 2024 | 16 | -2 | 41.47M | $2.82B | n/a | −2 |
| Q2 2024 | 18 | n/a | 42.26M | $1.79B | n/a | n/a |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 17.84M | +1.7% | $772.09M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 12.50M | +3.7% | $541.18M | 0.1% | ▲ Add | 4 | SEC ↗ ×7 |
| 3 | State Street Global Advisors ✦ (被动) | 6.61M | +6.1% | $286.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 6.40M | +11.2% | $277.23M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (被动) | 3.27M | +4.6% | $141.09M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 6 | Millennium Management ✦ | 1.47M | -37.5% | $63.82M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 1.01M | +70.8% | $43.65M | 0.0% | ▲ Add | 4 | SEC ↗ ×6 |
| 8 | Baillie Gifford ✦ | 832.57K | -17.8% | $36.04M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 9 | PRIMECAP Management ✦ | 479.30K | 0.0% | $20.75M | 0.0% | Held | 4 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 475.12K | -47.3% | $20.57M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 229.05K | -14.7% | $9.92M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 12 | Fisher Asset Management ✦ | 185.95K | +5.3% | $8.05M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 76.58K | -49.0% | $3.32M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 61.58K | +86.0% | $2.67M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 15 | Renaissance Technologies ✦ | 33.90K | 新增 | $1.47M | 0.0% | New | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 26.00K | -74.3% | $1.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | ARK Investment Management ✦ | 36 | -100.0% | $1,558 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $1.47M | 0.0% |
已清仓
| Soros Fund Management | $27.92M | 曾为 0.7% |
| Adage Capital Partners | $21.25M | 曾为 0.0% |
| Point72 Asset Management | $4.00M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 9 持有人, 64.35K 股份, $4.50M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据